PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsbreast neoplasms
MeSH D001943 - breast neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001941:Breast diseases
$
Success rate
D009371:Neoplasms by site
0 Companies
0 Drugs
Success rate
D001943: 
Breast neoplasms
D000069584:Unilateral breast neoplasms
0 Companies
0 Drugs
Success rate
D000071960:Breast carcinoma in situ
0 Companies
0 Drugs
Success rate
D018270:Ductal carcinoma breast
0 Companies
0 Drugs
Success rate
D018275:Lobular carcinoma
0 Companies
0 Drugs
Success rate
D018567:Male breast neoplasms
$
Success rate
D058922:Inflammatory breast neoplasms
0 Companies
0 Drugs
Success rate
D061325:Hereditary breast and ovarian cancer syndrome
0 Companies
0 Drugs
Success rate
D064726:Triple negative breast neoplasms
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
80%
337/422
Phase 2
41%
216/525
Phase 3
52%
182/349
Approved: 78Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Padagis
1
2
3
4
5
6
...
13
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use